Gao XM - Search Results

1

Inhibition of mTOR reduces chronic pressure-overload cardiac hypertrophy and fibrosis.

Gao XM, Wong G, Wang B, Kiriazis H, Moore XL, Su YD, Dart A, Du XJ. Gao XM, et al. J Hypertens. 2006 Aug;24(8):1663-70. doi: 10.1097/01.hjh.0000239304.01496.83. J Hypertens. 2006. PMID: 16877971

2

Genetic enhancement of ventricular contractility protects against pressure-overload-induced cardiac dysfunction.

Du XJ, Fang L, Gao XM, Kiriazis H, Feng X, Hotchkin E, Finch AM, Chaulet H, Graham RM. Du XJ, et al. Among authors: gao xm. J Mol Cell Cardiol. 2004 Nov;37(5):979-87. doi: 10.1016/j.yjmcc.2004.07.010. J Mol Cell Cardiol. 2004. PMID: 15522275

3

Regression of pressure overload-induced left ventricular hypertrophy in mice.

Gao XM, Kiriazis H, Moore XL, Feng XH, Sheppard K, Dart A, Du XJ. Gao XM, et al. Am J Physiol Heart Circ Physiol. 2005 Jun;288(6):H2702-7. doi: 10.1152/ajpheart.00836.2004. Epub 2005 Jan 21. Am J Physiol Heart Circ Physiol. 2005. PMID: 15665058 Free article.

4

Endogenous relaxin does not affect chronic pressure overload-induced cardiac hypertrophy and fibrosis.

Xu Q, Lekgabe ED, Gao XM, Ming Z, Tregear GW, Dart AM, Bathgate RA, Samuel CS, Du XJ. Xu Q, et al. Among authors: gao xm. Endocrinology. 2008 Feb;149(2):476-82. doi: 10.1210/en.2007-1220. Epub 2007 Nov 8. Endocrinology. 2008. PMID: 17991721

5

Reversal of cardiac fibrosis and related dysfunction by relaxin.

Du XJ, Xu Q, Lekgabe E, Gao XM, Kiriazis H, Moore XL, Dart AM, Tregear GW, Bathgate RA, Samuel CS. Du XJ, et al. Among authors: gao xm. Ann N Y Acad Sci. 2009 Apr;1160:278-84. doi: 10.1111/j.1749-6632.2008.03780.x. Ann N Y Acad Sci. 2009. PMID: 19416203

6

Chronic activation of the low affinity site of β1-adrenoceptors stimulates haemodynamics but exacerbates pressure-overload cardiac remodelling.

Kiriazis H, Tugiono N, Xu Q, Gao XM, Jennings NL, Ming Z, Su Y, Klenowski P, Summers RJ, Kaumann A, Molenaar P, Du XJ. Kiriazis H, et al. Among authors: gao xm. Br J Pharmacol. 2013 Sep;170(2):352-65. doi: 10.1111/bph.12272. Br J Pharmacol. 2013. PMID: 23750586 Free PMC article.

7

Inhibition of miR-154 Protects Against Cardiac Dysfunction and Fibrosis in a Mouse Model of Pressure Overload.

Bernardo BC, Nguyen SS, Gao XM, Tham YK, Ooi JY, Patterson NL, Kiriazis H, Su Y, Thomas CJ, Lin RC, Du XJ, McMullen JR. Bernardo BC, et al. Among authors: gao xm. Sci Rep. 2016 Mar 1;6:22442. doi: 10.1038/srep22442. Sci Rep. 2016. PMID: 26928825 Free PMC article.

8

Phosphoinositide 3-kinase p110α is a master regulator of exercise-induced cardioprotection and PI3K gene therapy rescues cardiac dysfunction.

Weeks KL, Gao X, Du XJ, Boey EJ, Matsumoto A, Bernardo BC, Kiriazis H, Cemerlang N, Tan JW, Tham YK, Franke TF, Qian H, Bogoyevitch MA, Woodcock EA, Febbraio MA, Gregorevic P, McMullen JR. Weeks KL, et al. Circ Heart Fail. 2012 Jul 1;5(4):523-34. doi: 10.1161/CIRCHEARTFAILURE.112.966622. Epub 2012 Jun 15. Circ Heart Fail. 2012. PMID: 22705768

9

Gene delivery of medium chain acyl-coenzyme A dehydrogenase induces physiological cardiac hypertrophy and protects against pathological remodelling.

Bernardo BC, Weeks KL, Pongsukwechkul T, Gao X, Kiriazis H, Cemerlang N, Boey EJH, Tham YK, Johnson CJ, Qian H, Du XJ, Gregorevic P, McMullen JR. Bernardo BC, et al. Clin Sci (Lond). 2018 Feb 8;132(3):381-397. doi: 10.1042/CS20171269. Print 2018 Feb 14. Clin Sci (Lond). 2018. PMID: 29358507

10

Lower risk of postinfarct rupture in mouse heart overexpressing beta 2-adrenergic receptors: importance of collagen content.

Gao XM, Dilley RJ, Samuel CS, Percy E, Fullerton MJ, Dart AM, Du XJ. Gao XM, et al. J Cardiovasc Pharmacol. 2002 Oct;40(4):632-40. doi: 10.1097/00005344-200210000-00018. J Cardiovasc Pharmacol. 2002. PMID: 12352327

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

653 results

Search Page